|
National Stock Number(NSN): 6505-01-156-1797 (6505011561797, 011561797)
| NIIN: |
01-156-1797 |
Item Name: |
LIDOCAINE HYDROCHLORIDE INJECTION |
INC: |
10155
|
| FSC: |
6505
|
Assignment Date: |
Jun-20-1983 |
CRIT: |
X |
IIG: |
10155 |
| ISC: |
C |
Date Standardized: |
Jun-18-1983 |
HMIC: |
P |
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Nov-01-2004 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
4 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
3 |
| NIIN: |
01-522-5340 |
Item Name: |
LIDOCAINE HYDROCHLORIDE INJECTION |
| FSC: |
6505 |
Replacement Date: |
Nov-01-2004 |
|
INC: |
10155 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
9149-87 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00015-9149-87 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00074-4904-01 |
0JNF5
|
ABBOTT LABORATORIES HOSPITAL PRODUCTS DIV CRITICAL CARE SYSTEMS BUSINESS UNIT |
H |
5 |
9 |
4 |
ZZ |
|
B |
|
|
|
|
|
NDC00074-4904-15 |
0JNF5
|
ABBOTT LABORATORIES HOSPITAL PRODUCTS DIV CRITICAL CARE SYSTEMS BUSINESS UNIT |
H |
5 |
9 |
4 |
ZZ |
|
B |
|
|
|
|
|
NDC00074-4904-15 |
60060
|
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00469-9149-87 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
M |
U |
1 |
A |
$13.02 |
PG |
|
C2201X- |
Feb-01-2002 |
H |
| DF |
JDC |
L |
|
M |
U |
1 |
F |
$13.02 |
PG |
|
------- |
Aug-01-1999 |
H |
| DN |
JDC |
L |
|
M |
U |
1 |
N |
$13.02 |
PG |
|
9L----- |
Aug-01-1999 |
H |
| DS |
JDC |
L |
|
M |
U |
1 |
D |
$13.02 |
PG |
|
------- |
Aug-01-1999 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DN |
R |
REFER TO NON-STD NON-DMSB REV |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE PER MILLILITER |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
5.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
10 |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
LIDOCAINE HYDROCHLORIDE INJECTION USP 5ML SYRINGE-NEEDLE UNIT 10S |
| FEAT |
SPECIAL FEATURES |
22 GAGE 1-1/2 IN. STERILE NEEDLE ATTACHED TO DISPOSABLE SYRINGE; UNIT QTY 10 |
| SUCB |
UNIT OF ISSUE CUBE |
0.087 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
1.13 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Nov-06-2000 |
3 |
H |
|
|
|
|
| FSKX |
|
Nov-06-2000 |
3 |
H |
|
|
|
|
| N9LM |
|
Nov-06-2000 |
3 |
H |
|
|
|
|
| VKX0 |
|
Nov-06-2000 |
3 |
H |
|
|
|
|
Replacement & Obsolete Information
| Obsolete NIIN Information |
|